SCHEMBL19347692

SCHEMBL19347692

CCc1ccc(C(C)(C)CC)cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.49
▸ MAPK1 P28482 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ LMNA P02545 1/20 0.49
▸ CASP3 P42574 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ SENP8 Q96LD8 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP6 Q9GZR1 1/20 0.49
▸ ESR1 P03372 5/20 0.41
▸ ESR2 Q92731 4/20 0.41
▸ AR P10275 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ NPSR1 Q6W5P4 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9177101 0.81 MAPK1 (0.40) RAB9AMAPK1NPC1SMN1; SMN2LMNA
SCHEMBL16245761 0.81 MAPK1 (0.41) RAB9AMAPK1NPC1SMN1; SMN2LMNA
SCHEMBL9154408 0.80 RAB9A (0.48) RAB9AMAPK1NPC1SMN1; SMN2LMNA
SCHEMBL21561726 0.80 MAPK1 (0.46) RAB9AMAPK1NPC1SMN1; SMN2LMNA
SCHEMBL25833534 0.80 NPC1 (0.46) RAB9AMAPK1NPC1SMN1; SMN2LMNA
SCHEMBL20811730 0.79 DAO (0.40) ESR1ESR2AREPHX2RXRA
SCHEMBL20811702 0.79 DAO (0.40) ESR1ESR2AREPHX2RXRA
SCHEMBL11394368 0.78 LMNA (0.45) RAB9AMAPK1NPC1SMN1; SMN2LMNA
SCHEMBL12603811 0.77 DAO (0.51) ESR1ESR2MAPTMEN1KMT2A
SCHEMBL4399352 0.76 ESR1 (0.72) RAB9AMAPK1NPC1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017156179-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 — — WO disclosed
Send feedback